THE ENCLOSED SLIDES ARE FREE FOR PUBLIC USE DECEMBER 2015 ACHP Drug Cost Chart Pack.
-
Upload
sherman-holmes -
Category
Documents
-
view
212 -
download
0
Transcript of THE ENCLOSED SLIDES ARE FREE FOR PUBLIC USE DECEMBER 2015 ACHP Drug Cost Chart Pack.
THE ENCLOSED SLIDES ARE FREE FOR PUBLIC USE
DECEMBER 2015
ACHP Drug Cost Chart Pack
The Spike in Drug Costs
Advancements in pharmaceuticals can result in drugs that offer fewer side effects, improve a patient’s quality of life and
save lives, but what if not everyone can afford them?
THERE’S ENORMOUS PRESSURE ON…..
Consumers andtheir families, whomay be faced withthe difficult choicebetween paying for
MS medications and other necessities.
Employers, who may be forced to make cuts to their
overall benefits package in order to fund rising health
care costs.
Health care providers, who treat an increase in
disease-related complications due in part
to non-adherence to costly medications.
Health plans andother payers, who
want to ensure people get the right
drugs and keep coverage affordable.
Federal government,which is bearingan ever-growing
share of the costs ofthese drugs, placing
increasing pressure on the federal budget.
The Spike in Drug Costs: Diabetes
GENERAL STATISTICS:
1 in 11 people in the U.S. has diagnosed or
undiagnosed diabetes. This is expected to increase to
1 in 3 people by 2050.
The cost of diagnosed diabetes
in 2012 was $245 billion.
The Spike in Drug Costs: Diabetes
Primarily because of escalating drug costs, spending on insulin and
other diabetes medications is expected to rise 18.3 percent over the next three years, a rate of increase 60 times greater than the recent income growth average of just 0.3 percent
across all households.
The Spike in Drug Costs: Diabetes
5
Diabetes Drugs with Significant Percent Price Changes Over Five Years(3/1/2010 – 2/28/2015)
Source: Medi-Span® Price Rx®. Figures reflect wholesale acquisition cost.Note: Price modifications will alter the values reflected above.
The Spike in Drug Costs: Multiple SclerosisGENERAL STATISTICS:
Multiple Sclerosis (MS) affects at least 400,000 people in the
United States and more than 2.5 million globally.
MS drugs help people manage their condition and enhance
their comfort and quality of life.
The cost of taking MS drugscan span a lifetime.
There is currently no cure for MS.
The Spike in Drug Costs:Multiple Sclerosis
Lemtrada, approved for sale in the U.S. in 2014, has a two-year course of treatment estimated at $158,000.
The Spike in Drug Costs: Multiple Sclerosis
8
MS Drugs with the Highest % Price Changes Since Launch for a 30-Day Supply
*Date listed is the first instance of available pricing data in Medi-Span®Price Rx®. The true launch date is earlier than that listed.Source: Medi-Span® Price Rx® and www.rxlist.com. Figures reflectwholesale acquisition cost.Note: Price modifications will alter the values reflected above.
The Spike in Drug Costs:Multiple Sclerosis
First-generation MS drugs, originally costing $8,000 - $11,000 per year, can now exceed $60,000 per person per year.
The Spike in Drug Costs:Multiple Sclerosis
The Spike in Drug Costs:Multiple Sclerosis
The new 40 mg dose of the widely prescribed drug Copaxone costs $5,0086 a month, yet shows no gain in efficacy over
the 20 mg dose.